-
公开(公告)号:US08168635B2
公开(公告)日:2012-05-01
申请号:US11629797
申请日:2005-06-20
申请人: John Cashman
发明人: John Cashman
IPC分类号: A61K31/502 , C07D237/30
CPC分类号: C07D413/06 , C07D237/32 , C07D307/14 , C07D405/04 , C07D405/06 , C07D405/12
摘要: Disclosed are agents having pharmacological activity against cellular receptors and intracellular signaling, particularly receptors and signaling pathways of central nervous system (CNS) neurotransmitters. Also disclosed are related methods and compositions for the treatment or prevention of diseases or disorders using the agents.
摘要翻译: 公开了具有针对细胞受体和细胞内信号传导的药理学活性的试剂,特别是中枢神经系统(CNS)神经递质的受体和信号通路。 还公开了使用这些试剂治疗或预防疾病或病症的相关方法和组合物。
-
公开(公告)号:US20130157947A1
公开(公告)日:2013-06-20
申请号:US13428647
申请日:2012-03-23
申请人: MARK MERCOLA , John Cashman , Marion Lanier , Erik Willems , Dennis Schade
发明人: MARK MERCOLA , John Cashman , Marion Lanier , Erik Willems , Dennis Schade
IPC分类号: C07D215/54 , C12N5/071 , A61K31/4709 , C07D401/10 , A61K31/475 , A61K31/47 , A61K38/18 , C12N5/079
CPC分类号: C07D215/54 , A61K31/47 , A61K31/4709 , A61K31/475 , A61K38/1841 , A61K38/1875 , C07D215/20 , C07D401/10 , C07D401/12 , C12N5/0618 , C12N5/0652 , C12N5/0655 , C12N5/0657 , C12N5/067 , C12N5/0676
摘要: Small molecule compounds and methods for stem cell differentiation are provided herein. An example of a class of compounds that may be used to practice the methods disclosed herein is represented by enantiomerically pure isomers of compounds of Formula I: or a chirally pure stereoisomer, pharmaceutically acceptable salt, or solvate thereof, wherein R1, R2, R3, R4, R5, R5′, R6, R6′, R7, R7′ are as described herein.
摘要翻译: 本文提供了小分子化合物和干细胞分化方法。 可用于实施本文公开的方法的一类化合物的实例由式I化合物的对映体纯的异构体或其手性纯的立体异构体,药学上可接受的盐或溶剂合物表示,其中R1,R2,R3, R4,R5,R5',R6,R6',R7,R7'如本文所述。
-
公开(公告)号:US20130123253A1
公开(公告)日:2013-05-16
申请号:US13461677
申请日:2012-05-01
申请人: John CASHMAN
发明人: John CASHMAN
IPC分类号: C07D413/06 , C07D237/32 , C07D405/12 , C07D307/14
CPC分类号: C07D413/06 , C07D237/32 , C07D307/14 , C07D405/04 , C07D405/06 , C07D405/12
摘要: Disclosed are agents having pharmacological activity against cellular receptors and intracellular signaling, particularly receptors and signaling pathways of central nervous system (CNS) neurotransmitters. Also disclosed are related methods and compositions for the treatment or prevention of diseases or disorders using the agents.
摘要翻译: 公开了具有针对细胞受体和细胞内信号传导的药理学活性的试剂,特别是中枢神经系统(CNS)神经递质的受体和信号通路。 还公开了使用这些试剂治疗或预防疾病或病症的相关方法和组合物。
-
公开(公告)号:US07623637B2
公开(公告)日:2009-11-24
申请号:US11619053
申请日:2007-01-02
申请人: Edward Hirschman , Jeffrey Bak , Avanish Pande , Aftab Hussain , John Cashman
发明人: Edward Hirschman , Jeffrey Bak , Avanish Pande , Aftab Hussain , John Cashman
IPC分类号: H04M15/00
CPC分类号: H04M15/41 , H04M15/00 , H04M15/50 , H04M15/53 , H04M2215/0164 , H04M2215/0172 , H04M2215/52
摘要: A system and method for reconciling the differences in pricing breakout definitions between telecommunication carriers so that rates and codes can be communicated between carriers in a format that is compatible with the systems of the respective carriers.
摘要翻译: 一种用于协调电信运营商之间的定价突破定义的差异的系统和方法,以便能够以与相应运营商的系统兼容的格式在载波之间传送速率和码。
-
公开(公告)号:US07167549B2
公开(公告)日:2007-01-23
申请号:US10638652
申请日:2003-08-11
申请人: Edward Hirschman , Jeffrey Bak , Avanish Pande , Aftab Hussain , John Cashman
发明人: Edward Hirschman , Jeffrey Bak , Avanish Pande , Aftab Hussain , John Cashman
IPC分类号: H04M15/00
CPC分类号: H04M15/41 , H04M15/00 , H04M15/50 , H04M15/53 , H04M2215/0164 , H04M2215/0172 , H04M2215/52
摘要: A system and method for reconciling the differences in pricing breakout definitions between telecommunication carriers so that rates and codes can be communicated between carriers in a format that is compatible with the systems of the respective carriers.
-
公开(公告)号:US09233926B2
公开(公告)日:2016-01-12
申请号:US13428647
申请日:2012-03-23
申请人: Mark Mercola , John Cashman , Marion Lanier , Erik Willems , Dennis Schade
发明人: Mark Mercola , John Cashman , Marion Lanier , Erik Willems , Dennis Schade
IPC分类号: C07D215/38 , A61K31/47 , C07D215/54
CPC分类号: C07D215/54 , A61K31/47 , A61K31/4709 , A61K31/475 , A61K38/1841 , A61K38/1875 , C07D215/20 , C07D401/10 , C07D401/12 , C12N5/0618 , C12N5/0652 , C12N5/0655 , C12N5/0657 , C12N5/067 , C12N5/0676
摘要: Small molecule compounds and methods for stem cell differentiation are provided herein. An example of a class of compounds that may be used to practice the methods disclosed herein is represented by enantiomerically pure isomers of compounds of Formula I: or a chirally pure stereoisomer, pharmaceutically acceptable salt, or solvate thereof, wherein R1, R2, R3, R4, R5, R5′, R6, R6′, R7, R7′ are as described herein.
摘要翻译: 本文提供了小分子化合物和干细胞分化方法。 可用于实施本文公开的方法的一类化合物的实例由式I化合物的对映体纯的异构体或其手性纯的立体异构体,药学上可接受的盐或溶剂合物表示,其中R1,R2,R3, R4,R5,R5',R6,R6',R7,R7'如本文所述。
-
公开(公告)号:US09023340B2
公开(公告)日:2015-05-05
申请号:US13540590
申请日:2012-07-02
申请人: John Cashman , Marion Lanier , Mark Mercola , Dennis Schade , Erik Willems
发明人: John Cashman , Marion Lanier , Mark Mercola , Dennis Schade , Erik Willems
IPC分类号: A01N63/00 , C07D401/12 , C07D209/76 , C12N5/077 , A61K35/34
CPC分类号: C07D401/12 , A61K35/34 , C07D209/76 , C12N5/0657 , C12N2501/415 , C12N2503/02 , C12N2506/02
摘要: Methods and small molecule compounds for stem cell differentiation and treatment of animals with diseases are provided. One example of a class of compounds that may be used is represented by the compound of Formula I and II: or a pharmaceutically acceptable salt or solvate thereof, wherein A, X, Q, R1, R2, R3, R4 are as described herein.
摘要翻译: 提供了用于具有疾病的动物的干细胞分化和治疗的方法和小分子化合物。 可以使用的一类化合物的一个实例由式I和II的化合物或其药学上可接受的盐或溶剂合物表示,其中A,X,Q,R 1,R 2,R 3,R 4如本文所述。
-
公开(公告)号:US20130177535A1
公开(公告)日:2013-07-11
申请号:US13540590
申请日:2012-07-02
申请人: John Cashman , Marion Lanier , Mark Mercola , Dennis Schade , Erik Willems
发明人: John Cashman , Marion Lanier , Mark Mercola , Dennis Schade , Erik Willems
IPC分类号: C07D401/12 , C12N5/071 , A61K35/34 , C07D209/76
CPC分类号: C07D401/12 , A61K35/34 , C07D209/76 , C12N5/0657 , C12N2501/415 , C12N2503/02 , C12N2506/02
摘要: Methods and small molecule compounds for stem cell differentiation and treatment of animals with diseases are provided. One example of a class of compounds that may be used is represented by the compound of Formula I and II: or a pharmaceutically acceptable salt or solvate thereof, wherein A, X, Q, R1, R2, R3, R4 are as described herein.
摘要翻译: 提供了用于具有疾病的动物的干细胞分化和治疗的方法和小分子化合物。 可以使用的一类化合物的一个实例由式I和II的化合物或其药学上可接受的盐或溶剂合物表示,其中A,X,Q,R 1,R 2,R 3,R 4如本文所述。
-
公开(公告)号:US20110281356A1
公开(公告)日:2011-11-17
申请号:US13107592
申请日:2011-05-13
申请人: Mark Mercola , John Cashman , Marion Lanier , Erik Willems
发明人: Mark Mercola , John Cashman , Marion Lanier , Erik Willems
IPC分类号: C12N5/0735 , C12N5/074 , C07D215/54
CPC分类号: C07D215/54 , C07D235/06 , C07D279/20 , C07D279/22 , C07D279/28 , C07D401/04 , C07D401/10 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/04 , C07D405/12 , C07D409/04 , C07D491/04
摘要: Methods and small molecule compounds for stem cell differentiation are provided. One example of a class of compounds that may be used is represented by the compound of Formula I: or a pharmaceutically acceptable salt or solvate thereof, wherein R1, R2, R3, R4, R5, R5′, R6, R6′, R7, R7′ are as described herein.
摘要翻译: 提供了干细胞分化的方法和小分子化合物。 可以使用的一类化合物的一个实例由式I化合物或其药学上可接受的盐或溶剂合物表示,其中R1,R2,R3,R4,R5,R5',R6,R6',R7, R7'如本文所述。
-
公开(公告)号:US20100159596A1
公开(公告)日:2010-06-24
申请号:US12561235
申请日:2009-09-16
申请人: Mark Mercola , Marcia Dawson , John Cashman
发明人: Mark Mercola , Marcia Dawson , John Cashman
IPC分类号: C12N5/074 , C07D215/14 , C07D491/04 , C07D403/12 , C07D413/12 , C07D417/06 , C07D223/18
CPC分类号: C07D215/54 , C07D235/06 , C07D279/20 , C07D279/22 , C07D279/28 , C07D401/04 , C07D401/10 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/04 , C07D405/12 , C07D409/04 , C07D491/04 , C12N5/0603 , C12N5/0606 , C12N5/0623
摘要: Methods and small molecule compounds for stem cell differentiation are provided. One example of a class of compounds that may be used is represented by the compound having the structure IA or IB in the form of free base or a pharmaceutically acceptable salt, hydrate, solvate or N-oxide thereof: R1 is independently hydrogen or (C1-C6)alkyl; R2 is independently hydrogen, (C1-C6)alkyl, aryl, or heteroaryl; R2′ is independently hydrogen, (C1-C6)alkyl, CF3 or C2F5; R3 is independently (C1-C6)alkyl, aryl, 2-tetrahydrofurylmethyl, an aliphatic tertiary amine, or 4-methoxybenzyl; or R2 and R3 may be joined together to form a 5 or 6 member ring lactone; R4 is independently hydrogen, (C1-C6)alkyl, a 2- or 4-R5-substituted aromatic ring selected from a 4-R5-phenyl or a 2-R5-5-pyridyl, aryl, heteroaryl, aliphatic tertiary amine or halogen; and R5, R5′, R6, R6′, R7, R7′, are each independently hydrogen, (C1-C6)alkyl, aryl, optionally substituted phenyl, heteroaryl, a heterocyclic ring, an aliphatic tertiary amine, or halogen.
摘要翻译: 提供了干细胞分化的方法和小分子化合物。 可以使用的一类化合物的一个实例由具有游离碱或其药学上可接受的盐,水合物,溶剂合物或N-氧化物形式的结构IA或IB的化合物表示:R1独立地是氢或(C1 -C 6)烷基; R2独立地是氢,(C1-C6)烷基,芳基或杂芳基; R2'独立地是氢,(C1-C6)烷基,CF3或C2F5; R3独立地为(C1-C6)烷基,芳基,2-四氢呋喃基甲基,脂肪族叔胺或4-甲氧基苄基; 或者R 2和R 3可以连接在一起以形成5或6元环内酯; R4独立地为氢,(C1-C6)烷基,选自4-R5-苯基或2-R5-5-吡啶基,芳基,杂芳基,脂族叔胺或卤素的2或4-R 5 - 取代的芳环 ; 和R 5,R 5',R 6,R 6',R 7,R 7'各自独立地为氢,(C 1 -C 6)烷基,芳基,任选取代的苯基,杂芳基,杂环,脂族叔胺或卤素。
-
-
-
-
-
-
-
-
-